Expert panel mulls nod to ‘additional dose’ of Covid vaccine to elderly

Credit: IndiaTimes- Published on November 29, 2021
Amid mounting fear over the new SARS-COV2 variant Omicron, an expert committee on Covid immunisation is considering to recommend an “additional dose” to those who are immunocompromised or are elderly and at high risk of infection or death due to Covid-19 infection, an official source said. A final decision on the issue will...

Video credit: Wibbitz Top Stories
Published on November 29, 2021 -  01:30
Vaccine for Omicron Variant Could Take Months, Says Moderna CEO
Vaccine for Omicron Variant , Could Take Months, Says Moderna CEO. CEO of Moderna Stephane Bancel says it could be months before a vaccine targeting the omicron variant of COVID-19 is made available, CNBC reports. CEO of Moderna Stephane Bancel says it could be months before a vaccine targeting the omicron variant of COVID-19 is made available, CNBC reports. Moderna reportedly expects the variant to be highly infectious, but data remains inconclusive. Mutations of the spike protein of the coronavirus have been linked to higher transmission rates. Mutations of the spike protein of the coronavirus have been linked to higher transmission rates. The World Health Organization says the omicron variant has experienced 30 of these mutations. The World Health Organization says the omicron variant has experienced 30 of these mutations. Experts say these mutations could possibly have a negative impact on the efficacy of the coronavirus vaccines. Experts say these mutations could possibly have a negative impact on the efficacy of the coronavirus vaccines. Depending on how much it dropped, we might decide on the one hand to give a higher dose of the current vaccine .., Stephane Bancel, CEO Moderna, via CNBC. Depending on how much it dropped, we might decide on the one hand to give a higher dose of the current vaccine .., Stephane Bancel, CEO Moderna, via CNBC. According to CNBC, Pfizer has started to develop its own vaccine to specifically target the omicron strain. According to CNBC, Pfizer has started to develop its own vaccine to specifically target the omicron strain. Pfizer CEO Albert Bourla says omicrons' impact on COVID-19 vaccines remains unclear. The company reportedly created a DNA template of the new strain on Nov. 26. ...we would be able to have the vaccine in less than 100 days, Albert Bourla, CEO Pfizer, via CNBC. ...we would be able to have the vaccine in less than 100 days, Albert Bourla, CEO Pfizer, via CNBC

You are here


💡 newsR Knowledge: Other News Mentions

COVID-19

Contagious disease caused by SARS-CoV-2
The fatalities have increased to nearly three-fold with 40 deaths reported in August, as compared to 10 in the last ten days of July.
Credit: DNA - Published 32 minutes ago

India logged 16,299 new coronavirus infections taking the total tally of cases to 4,42,06,996 while the active cases declined to 1,25,076, according to the Union..
Credit: IndiaTimes - Published 7 hours ago

North Korean leader Kim Jong Un has declared victory over COVID-19, while his sister has admitted he suffered "a fever" during the outbreak.
8 hours ago • Sky News
The Covid-19 cases in Delhi are on the rise, with upwards of 2000 cases being reported in the national capital over the last 24 hours.
Credit: DNA - Published 10 hours ago


Related videos from verified sources

Fauci Recommends Boosters Ahead of Potentially 'Dangerous' COVID-19 Holiday Spike 01:30
Credit: Wibbitz Top Stories - Published on November 22, 2021 


Thanksgiving air travel to rebound to 2019 levels; US opens COVID boosters to all adults 01:35
Credit: WTVR - Scripps - Published on November 21, 2021 


Key CDC panel recommends expanding COVID-19 boosters to all adults in US 02:21
Credit: ABC Action News - Published on November 19, 2021 


You might like